Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 6/20 | 0.52 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.52 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25899299 | 0.81 | CYP19A1 (0.48) | CYP19A1CYP17A1RIPK1TDP1LMNA | |
| SCHEMBL10064129 | 0.81 | CYP2C19 (0.47) | RIPK1CYP1A2ALDH1A1MAPT | |
| SCHEMBL31239310 | 0.77 | CYP19A1 (0.56) | CYP19A1CYP17A1TDP1LMNACYP1A2 | |
| SCHEMBL26753640 | 0.76 | ACHE (0.43) | RIPK1 | |
| SCHEMBL23746946 | 0.75 | CYP19A1 (0.53) | CYP19A1CYP17A1TDP1LMNACYP1A2 | |
| SCHEMBL26060005 | 0.75 | CYP3A4 (0.39) | RIPK1CYP3A4ALDH1A1 | |
| SCHEMBL25467999 | 0.75 | CYP2C19 (0.34) | RIPK1LMNA | |
| SCHEMBL12934601 | 0.73 | RIPK1 (0.57) | CYP19A1CYP17A1RIPK1TDP1LMNA | |
| SCHEMBL25147502 | 0.73 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1MAPT | |
| SCHEMBL10115946 | 0.73 | RAB9A (0.41) | RIPK1TDP1LMNAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11709427-B2 | Positive resist composition and pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-07-25 | — | — | US | disclosed |
| US-11709427-B2 | Positive resist composition and pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11709427-B2 | Positive resist composition and pattern forming process | EWSR1, PARG, VIM | CYP19A1 3736/4885CYP17A1 1964/4885RIPK1 1309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.